Sex differences in the use of intravenous rt-pa thrombolysis treatment for acute ischemic stroke: A meta-analysis

Stroke

Volumn 40, Issue 5, 2009, Pages 1743-1749

  Reeves, Mathew ^a,c   Bhatt, Archit ^a   Jajou, Peter ^a   Brown, Michael ^a   Lisabeth, Lynda ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Acute stroke; Quality of health care; Sex disparity; Thrombolysis

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; PLASMINOGEN ACTIVATOR; RECOMBINANT PROTEIN;

ARTICLE; BLOOD CLOT LYSIS; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DRUG EFFECT; HEALTH CARE QUALITY; HUMAN; MEDICAL DOCUMENTATION; META ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SYSTEMATIC REVIEW; ACUTE DISEASE; ADULT; AGED; BRAIN ISCHEMIA; DRUG UTILIZATION; EUROPE; FACTUAL DATABASE; FEMALE; MALE; MIDDLE AGED; NORTH AMERICA; REGISTER; REVIEW; RISK; SOCIAL PSYCHOLOGY; STATISTICAL ANALYSIS; STROKE; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; AGED; BRAIN ISCHEMIA; DATA INTERPRETATION, STATISTICAL; DATABASES, FACTUAL; DRUG UTILIZATION; EUROPE; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; NORTH AMERICA; ODDS RATIO; PLASMINOGEN ACTIVATORS; PREJUDICE; RECOMBINANT PROTEINS; REGISTRIES; SEX FACTORS; STROKE; TREATMENT OUTCOME;

EID: 65549135055     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.543181     Document Type: Article

References (42)

1. Bushnell CD, Hum P, Colton C, Miller VM, del Zoppo G, Elkind MSV, Stern B, Herrington D, Ford-Lynch G, Gorelick P, James A, Brown CA, Choi E, Bray P, Newby LK, Goldstein LB, Simpkins J. Advancing the study of stroke in women-Summary and recommendations for future research from an NINDS-sponsored multidisciplinary working group. Stroke. 2006;37:2387-2399.
2. Reeves MJ, Bushnell CD, Howard G, Gargano JW, Duncan PW, Lynch G, Khatiwoda A, Lisabeth L. Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol. 2008;7:915-926.
3. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581-1587.
4. Reeves MJ, Arora S, Broderick JP, Frankel M, Heinrich JP, Hickenbottom S, Karp H, LaBresh KA, Malarcher A, Moomaw CJ, Schwamm L, Weiss P. Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke. 2005;36:1232-1240.
5. Johnston SC, Fung LH, Gillum LA, Smith WS, Brass LM, Lichtman JH, Brown AN. Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers: the influence of ethnicity. Stroke. 2001;32:1061-1068.
6. Reid JM, Dai D, Gubitz GJ, Kapral MK, Christian C, Phillips SJ. Gender differences in stroke examined in a 10-year cohort of patients admitted to a Canadian teaching hospital. Stroke. 2008;39:1090-1095.
7. Brown DL, Lisabeth LD, Garcia NM, Smith MA, Morgenstern LB. Emergency department evaluation of ischemic stroke and TIA-The BASIC Project. Neurology. 2004;63:2250-2254.
8. Katzan IL, Hammer MD, Hixson ED, Furlan AJ, Abou-Chebl A, Nadzam DM. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol. 2004;61:346-350.
9. Reed SD, Cramer SC, Blough DK, Meyer K, Jarvik JG. Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals. Stroke. 2001;32:1832-1840.
10. Kapral MK, Fang J, Hill MD, Silver F, Richards J, Jaigobin C, Cheung AM. Sex differences in stroke care and outcomes: results from the Registry of the Canadian Stroke Network. Stroke. 2005;36:809-814.
11. Foerch C, Misselwitz B, Humpich M, Steinmetz H, Neumann-Haefelin T, Sitzer M. Sex disparity in the access of elderly patients to acute stroke care. Stroke. 2007;38:2123-2126.
12. Deng YZ, Reeves MJ, Jacobs BS, Birbeck GL, Kothari RU, Hickenbottom SL, Mullard AJ, Wehner S, Maddox K, Majid A. IV tissue plasminogen activator use in acute stroke-Experience from a statewide registry. Neurology. 2006;66:306-312.
13. Qureshi AI, Suri MF, Nasar A, He W, Kirmani JF, Divani AA, Prestigiacomo CJ, Low RB. Thrombolysis for ischemic stroke in the United States: data from National Hospital Discharge Survey 1999-2001. Neurosurgery. 2005;57:647-654; discussion 647-654.
14. Schumacher HC, Bateman BT, Boden-Albala B, Berman MF, Mohr JP, Sacco RL, Pile-Spellman J. Use of thrombolysis in acute ischemic stroke: analysis of the Nationwide Inpatient Sample 1999 to 2004. Ann Emerg Med. 2007;50:99-107.
15. Lisabeth LD, Brown DL, Morgenstern LB. Barriers to intravenous tissue plasminogen activator for acute stroke therapy in women. Gend Med. 2006;3:270-278.
16. Egger M, Davey Smith G, Altman DG. Systematic Reviews in Health Care: Meta-analysis in Context. 2001;London.
17. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539-1558.
18. Heuschmann PU, Berger K, Misselwitz B, Hermanek P, Leffmann C, Adelmann M, Buecker-Nott HJ, Rother J, Neundoerfer B, Kolominsky-Rabas PL. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group. Stroke. 2003;34:1106-1113.
19. Gargano JW, Wehner S, Reeves M. Sex differences in acute stroke care in a statewide stroke registry. Stroke. 2008;39:24-29.
20. Bateman BT, Schumacher HC, Boden-Albala B, Berman MF, Mohr JP, Sacco RL, Pile-Spellman J. Factors associated with in-hospital mortality after administration of thrombolysis in acute ischemic stroke patients: an analysis of the nationwide inpatient sample 1999 to 2002. Stroke. 2006;37:440-446.
21. Chapman KM, Woolfenden AR, Graeb D, Johnston DC, Beckman J, Schulzer M, Teal PA. Intravenous tissue plasminogen activator for acute ischemic stroke: A Canadian hospital's experience. Stroke. 2000;31: 2920-2924.
22. Wang DZ, Rose JA, Honings DS, Garwacki DJ, Milbrandt JC. Treating acute stroke patients with intravenous tPA. The OSF stroke network experience. Stroke. 2000;31:77-81.
23. Wiegand N, Luthy R, Vogel B, Straumann E, Beynon C, Bertel O, Oelz O, Caspar CB. Intravenous thrombolysis for acute ischaemic stroke in a hospital without a specialised neuro-intensive care unit. Swiss Med Wkly. 2004;134:14-17.
24. Katzan IL, Furlan AJ, Lloyd LE, Frank JI, Harper DL, Hinchey JA, Hammel JP, Qu A, Sila CA. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA. 2000;283: 1151-1158.
25. Arrich J, Mullner M, Lalouschek W, Greisenegger S, Crevenna R, Herkner H. Influence of socioeconomic status and gender on stroke treatment and diagnostics. Stroke. 2008;39:2066-2072.
26. Adams HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EFM. Guidelines for the early management of adults with ischemic stroke-A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups (Reprinted from Stroke, vol 38, pg 1655-1711, 2007). Circulation. 2007;115:e478-e534.
27. Menon SC, Pandey DK, Morgenstern LB. Critical factors determining access to acute stroke care. Neurology. 1998;51:427-432.
28. Goldstein LB, Edwards MG, Wood DP. Delay between stroke onset and emergency department evaluation. Neuroepidemiology. 2001;20:196-200.
29. Morris DL, Rosamond W, Madden K, Schultz C, Hamilton S. Prehospital and emergency department delays after acute stroke-The Genentech Stroke Presentation Survey. Stroke. 2000;31:2585-2590.
30. Smith MA, Doliszny K, Shahar E, McGovern P, Arnett D, Luepker R. Delayed hospital arrival for acute stroke: the Minnesota Stroke Survey. Ann Intern Med. 1998;129:190-196.
31. Di Carlo A, Lamassa M, Baldereschi M, Pracucci G, Basile AM, Wolfe CD, Giroud M, Rudd A, Ghetti A, Inzitari D. Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: data from a multicenter multinational hospital-based registry. Stroke. 2003;34:1114-1119.
32. Glader EL, Stegmayr B, Norrving B, Terent A, Hulter-Asberg K, Wester PO, Asplund K. Sex differences in management and outcome after stroke: a Swedish national perspective. Stroke. 2003;34:1970-1975.
33. Holroyd-Leduc JM, Kapral MK, Austin PC, Tu JV. Sex differences and similarities in the management and outcome of stroke patients. Stroke. 2000;31:1833-1837.
34. Roquer J, Campello AR, Gomis M. Sex differences in first-ever acute stroke. Stroke. 2003;34:1581-1585.
35. Labiche LA, Chan W, Saldin KR, Morgenstern LB. Sex and acute stroke presentation. Ann Emerg Med. 2002;40:453-460.
36. Niewada M, Kobayashi A, Sandercock PA, Kaminski B, Czlonkowska A. Influence of gender on baseline features and clinical outcomes among 17,370 patients with confirmed ischaemic stroke in the international stroke trial. Neuroepidemiology. 2005;24:123-128.
37. Barroso B, Larrieu JM, Morisset C, Carlier P, Bersani D, Dakar A, Lagabrielle JF, Larribau E, Lippa A, Mangon H, Montaut N, Rouanet F. [Feasibility of stroke thrombolysis at Pau Hospital, France]. Presse Med. 2007;36:859-866.
38. Bray JE, Coughlan K, Bladin C. Thrombolytic therapy for acute ischaemic stroke: successful implementation in an Australian tertiary hospital. Intern Med J. 2006;36:483-488.
39. Heuschmann PU, Kolominsky-Rabas PL, Roether J, Misselwitz B, Lowitzsch K, Heidrich J, Hermanek P, Leffmann C, Sitzer M, Biegler M, Buecker-Nott HJ, Berger K. Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy. JAMA. 2004;292:1831-1838.
40. Schwammenthal Y, DrescherMJ, Merzeliak O, Tsabari R, Bruk B, Feibel M, Hoffman C, Bakon M, Rotstein Z, Chapman J, Tanne D. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience. Isr Med Assoc J. 2004;6:70-74.
41. Walters MR, Muir KW, Harbison J, Lees KR, Ford GA. Intravenous thrombolysis for acute ischaemic stroke: preliminary experience with recombinant tissue plasminogen activator in the UK. Cerebrovasc Dis. 2005;20:438-442.
42. WeimarC, Kraywinkel K, Maschke M, DienerHC. Intravenous thrombolysis in German stroke units before and after regulatory approval of recombinant tissue plasminogen activator. Cerebrovasc Dis. 2006;22:429-431.